Welcome to our dedicated page for Positron SEC filings (Ticker: POSC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering what drives revenue for a niche cardiac PET manufacturer like Positron Corporation? Investors usually begin with the annual report, yet locating R&D spending or FDA-related risk factors inside a dense 10-K can be challenging. Our platform answers the natural question, “How do I understand Positron SEC documents with AI?”
Stock Titan’s AI summarizes every Positron quarterly earnings report 10-Q filing, flags wording changes, and translates technical nuclear-medicine jargon into plain English. Need real-time alerts on Positron insider trading Form 4 transactions? We stream each filing the moment it hits EDGAR, so you can monitor executive stock moves as they happen.
Use the left-side filter to jump straight to:
- 10-K highlights that pinpoint unit sales of the dedicated cardiac PET scanner—Positron annual report 10-K simplified
- Fresh 8-Ks when clinical-trial milestones occur—Positron 8-K material events explained
- DEF 14A proxy details on management pay—Positron proxy statement executive compensation
- Positron Form 4 insider transactions real-time for pattern analysis
Our AI-powered summaries surface practical insights: compare quarter-over-quarter scanner backlog, track segment gross margin shifts, or spot wording changes around reimbursement risk. Instead of scrolling through hundreds of pages, you’ll quickly answer, “What does Positron report in their SEC filings?” and “Which executives are buying shares?” All filings, from S-1s to late-breaking 8-Ks, sit one click away—already distilled for faster, smarter decisions.
Positron Corporation disclosed that on December 23, 2025 it entered into a Subscription Agreement with a single investor to sell 1,333,333 shares of its common stock for an aggregate purchase price of
The shares were issued in a private transaction not registered under the Securities Act of 1933, relying on the Regulation S exemption. This issuance represents new equity capital for Positron and results in additional common shares outstanding. The company also filed the Subscription Agreement and a related press release as exhibits.
Positron Corporation reports a change in its independent auditor. Freed Maxick P.C. resigned as the company’s independent registered public accounting firm effective October 31, 2025. On December 10, 2025, the company appointed Salberg & Company, P.A. as its new independent registered public accounting firm.
Salberg has been engaged to audit Positron Corporation’s financial statements for the year ended December 31, 2025 and to review interim financial statements for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026. The company states that during the two most recent fiscal years and through December 10, 2025, it did not consult with Salberg on the application of accounting principles, the type of audit opinion that might be issued, or on any matter involving a “disagreement” or “reportable event” as defined in SEC rules.
FAQ
What is the current stock price of Positron (POSC)?
What is the market cap of Positron (POSC)?
